A vaccine strategy against AIDS: an HIV gp41 peptide immunization prevents NKp44L expression and CD4+ T cell depletion in SHIV-infected macaques
about
Sang Froid in a time of trouble: is a vaccine against HIV possible?Perspectives for immunotherapy: which applications might achieve an HIV functional cure?Viremic HIV infected individuals with high CD4 T cells and functional envelope proteins show anti-gp41 antibodies with unique specificity and functionLysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals.HIV gp41 engages gC1qR on CD4+ T cells to induce the expression of an NK ligand through the PIP3/H2O2 pathway.Challenges in HIV Vaccine Research for Treatment and Prevention.Innate immunity against HIV: a priority target for HIV prevention researchRole of the Fas/FasL pathway in HIV or SIV diseaseNatural cytotoxicity receptors: broader expression patterns and functions in innate and adaptive immune cells.Synthetic immunotherapy induces HIV virus specific Th1 cytotoxic response and death of an HIV-1 infected human cell line through classic complement activation.Natural killer cells in immunodefense against infective agents.Pathologic natural killer cell subset redistribution in HIV-1 infection: new insights in pathophysiology and clinical outcomes.New challenges in therapeutic vaccines against HIV infection.Neutralizing Antibodies Against a Specific Human Immunodeficiency Virus gp41 Epitope are Associated With Long-term Non-progressor Status.Optimization of the EC26-2A4 epitope in the gp41 membrane proximal external region (MPER) targeted by neutralizing antibodies from an elite controller.The Hard Way towards an Antibody-Based HIV-1 Env Vaccine: Lessons from Other Viruses.
P2860
Q27487961-0799F577-268B-40B2-B816-8C7C253FFA0EQ28078726-33D0506C-57A0-42CB-89B3-3129DA8BF8A1Q28732293-04C3FBCF-0D9C-429A-9E19-107C0CE00EF2Q30845033-BE1CCF9D-6552-4056-8320-58C1FC881F91Q33628767-775ED3ED-14FD-4C16-8032-3E7D42B846A7Q34148683-D5FDBC9F-DA95-4F9D-88F7-7B27C517B991Q34243462-117C8981-A09E-4761-9155-4119D017EACAQ34612821-24BFF0E4-E4B7-4184-8F69-25CE890F289CQ36701917-5FB7180A-6A3D-4E14-807F-58B5A2A8DEA8Q36766857-4869A510-F702-4D47-9AE8-7986AE4F1780Q37178929-B7D84424-A6CD-4685-B81F-17226F1679BCQ37774818-D52C98A3-D201-4EDF-BB87-6D4CA35FFCABQ38692205-5F5A7A7B-309D-4DA5-8977-AB175A874552Q40120996-7D7EFAFE-77E9-43E9-B7B2-3329CC8B8EA2Q47269868-32BC3CBB-EAC7-49DA-851F-46CE9BCE5A63Q52584646-7AE319EF-0254-4B57-A007-306AFB28277A
P2860
A vaccine strategy against AIDS: an HIV gp41 peptide immunization prevents NKp44L expression and CD4+ T cell depletion in SHIV-infected macaques
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
A vaccine strategy against AID ...... tion in SHIV-infected macaques
@en
type
label
A vaccine strategy against AID ...... tion in SHIV-infected macaques
@en
prefLabel
A vaccine strategy against AID ...... tion in SHIV-infected macaques
@en
P2860
P356
P1476
A vaccine strategy against AID ...... tion in SHIV-infected macaques
@en
P2093
Roger Le Grand
Vincent Vieillard
P2860
P304
P356
10.1073/PNAS.0711629105
P407
P577
2008-01-30T00:00:00Z